Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Rossof

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Oncology|June 1, 1982
Randomized evaluation of combination chemotherapy vs. observation alone following response or stabilization after oophorectomy for metastatic breast cancer in premenopausal womenA H Rossof, R Gelman, R H Creech
Cancer|December 1, 1972
Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP)A H Rossof, R E Slayton, C P Perlia
Cancer Treatment Reports|November 11, 1976
Phase II evaluation of cis-diamminedichloroplatinum(II) in lung cancerA H Rossof, J D Bearden, C A Coltman
Cancer|October 1, 1978
Recognition and successful management in pulmonary aspergillosis in leukemiaA J Sinclair, A H Rossof, C A Coltman
Cancer Chemotherapy and Pharmacology|January 1, 1980
MItomycin C, methyl-CCNU and 5-fluorouracil in the treatment of metastatic colorectal carcinomaP D Bonomi, G Chandra, A H Rossof, et al.
The New England Journal of Medicine|March 7, 1991
The high cost of levamisole for humansA H Rossof, T R Philpot, R S Bunch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Multiple primary malignanciesR S Hoffman, A H Rossof, R Pazdur, et al.
Epidemiology (Cambridge, Mass.)|July 1, 1992
Serum cholesterol, beta-carotene, and risk of lung cancerR B Shekelle, C C Tangney, A H Rossof, et al.
Cancer Treatment Reports|September 1, 1979
Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group StudyA H Rossof, C A Coltman, S E Jones, et al.
Cancer Treatment Reports|October 1, 1978
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinomaN J Vogelzang, P D Bonomi, A H Rossof, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Oncology|June 1, 1982
Randomized evaluation of combination chemotherapy vs. observation alone following response or stabilization after oophorectomy for metastatic breast cancer in premenopausal womenA H Rossof, R Gelman, R H Creech
Cancer|December 1, 1972
Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP)A H Rossof, R E Slayton, C P Perlia
Cancer Treatment Reports|November 11, 1976
Phase II evaluation of cis-diamminedichloroplatinum(II) in lung cancerA H Rossof, J D Bearden, C A Coltman
Cancer|October 1, 1978
Recognition and successful management in pulmonary aspergillosis in leukemiaA J Sinclair, A H Rossof, C A Coltman
Cancer Chemotherapy and Pharmacology|January 1, 1980
MItomycin C, methyl-CCNU and 5-fluorouracil in the treatment of metastatic colorectal carcinomaP D Bonomi, G Chandra, A H Rossof, et al.
The New England Journal of Medicine|March 7, 1991
The high cost of levamisole for humansA H Rossof, T R Philpot, R S Bunch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Multiple primary malignanciesR S Hoffman, A H Rossof, R Pazdur, et al.
Epidemiology (Cambridge, Mass.)|July 1, 1992
Serum cholesterol, beta-carotene, and risk of lung cancerR B Shekelle, C C Tangney, A H Rossof, et al.
Cancer Treatment Reports|September 1, 1979
Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group StudyA H Rossof, C A Coltman, S E Jones, et al.
Cancer Treatment Reports|October 1, 1978
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinomaN J Vogelzang, P D Bonomi, A H Rossof, et al.
Pageof 4